10 months ago
NTLA
AnalystsGreg HarrisonGreg Harrison's Stock Forecasts
AnalystsGreg Harrison
Analyst Ranking
Top 13%
#559 out of 4555 analysts
Average Return
+21.68%
Win Rate
57%13 out of 23
Risk vs Reward
Poor
Good
Greg Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Iveric Bio IncISEE | +244.89% | $11.25 | $38.80 | 2022-06-07 - 2023-06-07 | Strong Buy |
Liquidia CorpLQDA | +117.00% | $4.03 | $8.75 | 2022-05-25 - 2023-05-25 | Strong Buy |
Rocket Pharmaceuticals IncRCKT | +96.61% | $21.84 | $42.94 | 2020-06-24 - 2021-06-25 | Strong Buy |
Athersys IncATHXQ | +83.21% | $5.35 | $0.90 | 2022-05-22 - 2023-05-22 | Sell |
Neurogene IncNGNE | +79.04% | $128.80 | $230.60 | 2020-03-15 - 2021-03-16 | Strong Buy |
Greg Harrison Analyst Color
Get additional color on Greg Harrison's coverage of popular stocks
Greg Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Liquidia CorpLQDA | 2 | Strong Buy | $15.00 | +12.87% | Maintains | 4 months ago |
Beam Therapeutics IncBEAM | 2 | Hold | $35.00 | +46.44% | Downgrades | 4 months ago |
Travere Therapeutics IncTVTX | 2 | Strong Buy | $27.00 | +372.03% | Maintains | 7 months ago |
Keros Therapeutics IncKROS | 1 | Strong Buy | $65.00 | +11.53% | Initiates Coverage On | 9 months ago |
Intellia Therapeutics IncNTLA | 2 | Strong Buy | $91.00 | +321.88% | Maintains | 10 months ago |
Stoke Therapeutics IncSTOK | 3 | Hold | $12.00 | -0.41% | Upgrades | a year ago |
Sangamo Therapeutics IncSGMO | 1 | Sell | $1.50 | +193.54% | Downgrades | a year ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $39.00 | N/A | Initiates Coverage On | a year ago |
Rocket Pharmaceuticals IncRCKT | 2 | Strong Buy | $35.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 2 | Hold | $15.00 | N/A | Maintains | a year ago |
Omeros CorpOMER | 1 | Sell | $3.00 | N/A | Downgrades | a year ago |
Senti Biosciences IncSNTI | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Neurogene IncNGNE | 2 | Sell | $5.00 | N/A | Downgrades | 2 years ago |
Radius Health IncRDUS1 | 1 | Hold | $8.00 | N/A | Upgrades | 2 years ago |
Iveric Bio IncISEE | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Athersys IncATHXQ | 4 | Sell | $6.25 | N/A | Downgrades | 2 years ago |
Sentinelone IncS | 1 | Strong Buy | $54.00 | N/A | Maintains | 2 years ago |
Nektar TherapeuticsNKTR | 2 | Sell | $6.00 | N/A | Downgrades | 2 years ago |
Agios Pharmaceuticals IncAGIO | 1 | Strong Buy | $54.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.